12-98534034-A-G
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000266732.8(TMPO):c.1777A>G(p.Met593Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000205 in 1,608,458 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M593T) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000266732.8 missense
Scores
Clinical Significance
Conservation
Publications
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: ClinGen, Orphanet
- dilated cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| TMPO | NM_001032283.3 | c.565+2196A>G | intron_variant | Intron 3 of 8 | ENST00000556029.6 | NP_001027454.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0000460  AC: 7AN: 152246Hom.:  0  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.0000160  AC: 4AN: 250028 AF XY:  0.00000740   show subpopulations 
GnomAD4 exome  AF:  0.0000179  AC: 26AN: 1456212Hom.:  0  Cov.: 32 AF XY:  0.0000152  AC XY: 11AN XY: 723178 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000460  AC: 7AN: 152246Hom.:  0  Cov.: 33 AF XY:  0.0000807  AC XY: 6AN XY: 74382 show subpopulations 
ClinVar
Submissions by phenotype
not specified    Uncertain:1 
The p.M593V variant (also known as c.1777A>G), located in coding exon 4 of the TMPO gene, results from an A to G substitution at nucleotide position 1777. The methionine at codon 593 is replaced by valine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Loeys-Dietz syndrome 2    Uncertain:1 
This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 593 of the TMPO protein (p.Met593Val). This variant is present in population databases (rs369840957, gnomAD 0.01%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 576173). This variant has not been reported in the literature in individuals affected with TMPO-related conditions. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at